NEW YORK (GenomeWeb) – The US Food and Drug Administration (FDA) announced today that it is offering a panel of human plasma samples to assist in the regulatory evaluation of serological tests to detect recent Zika virus infection.
NEW YORK (GenomeWeb) – The US Food and Drug Administration (FDA) announced today that it is offering a panel of human plasma samples to assist in the regulatory evaluation of serological tests to detect recent Zika virus infection.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.